Hiroshi Yamazaki

Hiroshi Yamazaki is an experienced business development professional specializing in the life sciences and biotechnology sectors. Currently serving as Managing Director at Probio Corporation since April 2022, Senior Director of Business Development at both Owkin and AcademicLabs, and a Business Development Specialist at Deep Pharma Intelligence, Hiroshi has a robust background in facilitating business expansion and market access. Previous roles include Senior Director positions at OncologyPipeline and Global Pricing Innovations, as well as significant contributions to Evaluate Ltd as the first Japanese Senior Director in Asia Pacific. Hiroshi's career commenced at Thomson Reuters and LIQUENT, focusing on regulatory solutions and pharmaceutical R&D insights, thereby ensuring a comprehensive understanding of the global pharmaceutical landscape.